Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4

Autor: Abdel Rahman N, Zekri, Hanaa M Alam, El-Din, Abeer A, Bahnassy, Mohsen M, Khaled, Ashraf, Omar, Inas, Fouad, Mahmoud, El-Hefnewi, Fouad, Thakeb, Mostafa, El-Awady

Publikováno v: Virology Journal, Vol 4, Iss 1, p 16 (2007)
Virology Journal

Background HCV is one of the major health problems in Egypt, where it is highly prevalent. Genotype 4 is the most common genotype of HCV and its response to treatment is still a controversy. Methods HCV genotype 4 quasispecies diversity within the 5'

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4bf4cd57573d1364981e3d4b4c7ba530
http://www.virologyj.com/content/4/1/16

Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection

Autor: Tarek Mansour, Zeinab K. Hassan, Mohsen M Khaled, Manal H El-Sayed, Nahed I Mohamed, Mohamed M. Hafez, Abdel-Rahman N. Zekri

Publikováno v: Virology Journal
Virology Journal, Vol 4, Iss 1, p 74 (2007)

Background There are eight genotypes of hepatitis B virus (A-H) and subgenotypes are recognized. Genotyping can be accomplished based on a partial sequence of HBV genome such as the pre-S or S gene. Several methods have been developed and used for HB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85991dcec2b60c28f9c3fd6be4275386
https://doi.org/10.1186/1743-422x-4-74

A Phase II, Randomized, Double-Blind, Double-Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients Newly Diagnosed with Type 2 Diabetes Mellitus.

Autor: Assaad-Khalil S; Department of Internal Medicine, Unit of Diabetology, Lipidology & Metabolism Faculty of Medicine, Alexandria University, Alexandria, Egypt., Elkafrawy N; Department of Internal Medicine, Unit of Endocrinology & Diabetes, Faculty of Medicine, Menoufia University, Shebin El Kom, Menoufia, Egypt., Khaled M; Egyptian National Institute of Diabetes and Endocrinology, Cairo, Egypt., Mogeib O; Department of Endocrinology, National Research Center, Giza, Egypt., Badr H; Department of Internal Medicine, Unit of Endocrinology & Diabetes, Faculty of Medicine, Menoufia University, Shebin El Kom, Menoufia, Egypt., Rashwan A; Unit of Critical Care Medicine, Fayoum General Hospital, Fayoum, Egypt., Youssef M; Department of Cardiovascular Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Eltamawy K; Unit of Cardiology, Assiut General Hospital, Assiut, Egypt., Mohamed S; School of Pharmaceutical Sciences, University Sains Malaysia, George, Malaysia.

Publikováno v: Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Sep 27; Vol. 2022, pp. 9176026. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).